Benign breast disease and breast cancer risk: Potential role for antiestrogens

Clinical Cancer Research

Volumn 7, Issue 12 SUPPL., 2001, Pages

  Schnitt, S J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; TAMOXIFEN;

BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST HYPERPLASIA; CANCER RISK; CONFERENCE PAPER; FOLLOW UP; HISTOLOGY; HUMAN; PRIORITY JOURNAL; RISK FACTOR;

BREAST DISEASES; BREAST NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 0035661118     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Anatomic indicators (histologic and cytologic) of increased breast cancer risk
2. Fibrocystic. "Disease" of the breast-a nondisease?
3. Chronic mastopathy and breast cancer: A follow-up study
4. Risk factors for breast cancer in women with proliferative breast disease
5. A prospective study of the development of breast cancer in 16,692 women with benign breast disease
6. A comparison of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast
7. Benign breast disease and breast cancer: A case-control study in a cohort in Italy
8. A prospective study of benign breast disease and the risk of breast cancer
9. Risk of breast cancer after benign breast diseases: Variation by histologic type, degree of atypia, age at biopsy and length of follow-up
10. Histologic types of benign breast disease and the risk of breast cancer
11. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
12. Prognostic significance of benign proliferative breast disease
13. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types
14. Atypical hyperplastic lesions of the female breast: A long-term follow-up study
15. Benign breast changes and the risk for subsequent breast cancer. An update of the 1985 consensus statement
16. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia
17. Ductal involvement by cells of atypical lobular hyperplasia: A long-term follow-up study of cancer risk
18. Histologic sampling of grossly benign breast biopsies. How much is enough?
19. How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic-pathologic correlative study
20. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically
21. Both atypical lobular hyperplasia (ALH) and atypical ductal hyperplasia (ADH) predict for bilateral breast cancer risk
22. Pathologic features of breast cancers in women with prior benign breast disease
23. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia
24. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-l Study
25. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk
26. Biopsy confirmed benign breast disease
27. Estrogen receptor expression in benign breast epithelium and breast cancer risk
28. A hypersensitive estrogen receptor-α mutation in premalignant breast lesions